open access publication

Article, 2023

Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: update on a COVID era ILROG collaborative report

Hematological Oncology, ISSN 1099-1069, 0278-0232, Volume 41, S2, Pages 609-610, 10.1002/hon.3164_458

Contributors

Yang, J. [1] Gunther, Jillian Rebecca 0000-0001-5727-7594 [2] Hajj, Carla 0000-0001-8774-1845 [3] Ng, Andrea K [4] Brady, Jessica [5] Cheng, Shu-Hui 0000-0002-4223-2358 [6] Levis, Mario 0000-0002-7668-3296 [7] Qi, Shu-Nan 0000-0002-0921-8052 [8] Mikhaeel, Nabegh George 0000-0003-0359-0328 [5] Ricardi, Umberto 0000-0003-4406-7621 [7] Illidge, Tim Martin 0000-0003-3191-7324 [9] Turin, A [10] Knafl, Mark K 0000-0002-3953-2173 [2] Specht, Lena K 0000-0002-6902-2190 [11] Dabaja, Bouthaina Shbib [2] Yahalom, Joachim 0000-0003-1658-8585 [3]

Affiliations

  1. [1] Washington University in St. Louis
  2. [NORA names: United States; America, North; OECD];
  3. [2] The University of Texas MD Anderson Cancer Center
  4. [NORA names: United States; America, North; OECD];
  5. [3] Memorial Sloan Kettering Cancer Center
  6. [NORA names: United States; America, North; OECD];
  7. [4] Dana-Farber Cancer Institute
  8. [NORA names: United States; America, North; OECD];
  9. [5] Guy's Cancer Centre, linical Oncology and Radiotherapy, London, UK
  10. [NORA names: United Kingdom; Europe, Non-EU; OECD];

Keywords

collaborative report, efficacy, hematologic malignancies, hypofractionated radiation therapy, malignancy, patients, radiation therapy, reports, therapy, toxicity

Data Provider: Digital Science